Clinical Trial Update: Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating dual antithrombotic therapy with dabigatran and ticagrelor in patients with acute coronary syndrome and non-valvular atri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Syndrome
• Percutaneous Coronary Intervention

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Medical University of Gdansk | Conditions: Atrial Fibrillation, Antithrombotic Therapy | Phase 4 | Status: UNKNOWN